Abstract:Background: Pancreatic cancer, a formidable gastrointestinal neoplasm, is characterized by its insidious onset, rapid progression, and resistance to treatment, which often lead to a grim prognosis. While the complex pathogenesis of pancreatic cancer is well recognized, recent attention has focused on the oncogenic roles of senescent tumor-associated fibroblasts. However, their precise role in pancreatic cancer remains unknown. Resveratrol is a natural polyphenol known for its multifaceted biological actions, including antioxidative and neuroprotective properties, as well as its potential to inhibit tumor proliferation and migration. Our current investigation builds on prior research and reveals the remarkable ability of resveratrol to inhibit pancreatic cancer proliferation and metastasis. Aim: To explore the potential of resveratrol in inhibiting pancreatic cancer by targeting senescent tumor-associated fibroblasts. Methods: Immunofluorescence staining of pancreatic cancer tissues revealed prominent coexpression of α-SMA and p16. HP-1 expression was determined using immunohistochemistry. Cells were treated with the senescence-inducing factors known as 3CKs. Long-term growth assays confirmed that 3CKs significantly decreased the CAF growth rate. Western blotting was conducted to assess the expression levels of p16 and p21. Immunofluorescence was performed to assess LaminB1 expression. Quantitative real-time polymerase chain reaction was used to measure the levels of several senescence-associated secretory phenotype factors, including IL-4, IL-6, IL-8, IL-13, MMP-2, MMP-9, CXCL1, and CXCL12. A scratch assay was used to assess the migratory capacity of the cells, whereas Transwell assays were used to evaluate their invasive potential. Results: Specifically, we identified the presence of senescent tumor-associated fibroblasts within pancreatic cancer tissues, linking their abundance to cancer progression. Intriguingly, Resveratrol effectively eradicated these fibroblasts and hindered their senescence, which consequently impeded pancreatic cancer progression. Conclusion: This groundbreaking discovery reinforces Resveratrol's stature as a potential antitumor agent and positions senescent tumor-associated fibroblasts as pivotal contenders in future therapeutic strategies against pancreatic cancer.

Resveratrol in the Treatment of Pancreatic Cancer.

Resveratrol Induces Apoptosis in Pancreatic Cancer Cells

Dietary Polyphenol Quercetin Targets Pancreatic Cancer Stem Cells.

Anticancer Effect and Enhanced Chemotherapy Potential of Resveratrol in Human Pancreatic Cancer Cell Lines

Resveratrol: an Overview of Its Anti-Cancer Mechanisms

Resveratrol Ameliorates the Malignant Progression of Pancreatic Cancer by Inhibiting Hypoxia-induced Pancreatic Stellate Cell Activation.

Resveratrol and cancer treatment: updates

Resveratrol inhibits pancreatic cancer proliferation and metastasis by depleting senescent tumor-associated fibroblasts

Resveratrol Inhibits Proliferation and Induces Apoptosis Through the Hedgehog Signaling Pathway in Pancreatic Cancer Cell

Resveratrol Slows the Tumourigenesis of Pancreatic Cancer by Inhibiting NFκB Activation

Resveratrol inhibits the epithelial-mesenchymal transition of pancreatic cancer cells via suppression of the PI-3K/Akt/NF-κB pathway.

Quercetin Impact in Pancreatic Cancer: An Overview on Its Therapeutic Effects

Resveratrol plays dual roles in pancreatic cancer cells

Resveratrol for Cancer Therapy: Challenges and Future Perspectives

Resveratrol enhances the chemotherapeutic response and reverses the stemness induced by gemcitabine in pancreatic cancer cells via targeting SREBP1

Resveratrol Inhibits Hypoxia-Driven ROS-induced Invasive and Migratory Ability of Pancreatic Cancer Cells Via Suppression of the Hedgehog Signaling Pathway.

Resveratrol Suppresses the Epithelial-to-mesenchymal Transition in PC-3 Cells by Down-Regulating the PI3K/AKT Signaling Pathway

PARP inhibitors in pancreatic cancer: molecular mechanisms and clinical applications

Resveratrol Inhibits Hyperglycemia-Driven ROS-induced Invasion and Migration of Pancreatic Cancer Cells Via Suppression of the ERK and P38 MAPK Signaling Pathways.

Aspirin: A Potential Therapeutic Approach in Pancreatic Cancer

Role of Dietary Cancer-Preventive Phytochemicals in Pancreatic Cancer Stem Cells